A photo of a CanSino scientist holding a vial of its Ad5-based COVID-19 vaccine. CanSino Biologics began a clinical trial of its Ad5-based COVID-19 vaccine on March 16. Credit: CanSino Biologics ...

In the realm of gene therapy and genetic engineering, viral vectors have emerged as indispensable tools for delivering genetic material to cells. These modified viruses possess the ability to ...

In a recent study posted to the bioRxiv* preprint server, researchers proposed rotavirus (RV)-based vaccine vectors with the potential for developing polyvalent vaccines targeting multiple enteric ...

Viruses have been evolving for millions of years, improving their ability to transfer genetic material to the hosts they infect. When it comes to gene transfer, viruses are efficient and effective. So ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...

The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC ...

Researchers have developed a new methodology that uses artificial intelligence tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used in ...

Targeted delivery of biological agents to atherosclerotic plaques may provide a novel treatment and/or useful tool for imaging of atherosclerosis in vivo. However, there are no known viral vectors ...